Pieris Pharmaceuticals Inc (PIRS)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-04-10 | 2025-04-09 | B Purchase | Non-Executive Director |
1,000
+22.6%
20.27USD 50,472 |
1,000 +22.6% | 20.27 | USD 100,000 | |
| 2025-04-10 | 2025-04-09 | B Purchase | Non-Executive Director |
1,000
+1.4%
20.13USD 50,325 |
1,000 +1.4% | 20.13 | USD 100,000 | |
| 2024-12-19 | 2024-12-18 | B Purchase | Non-Executive Director |
4,000
+2.3%
12.93USD 51,720 |
4,000 +2.3% | 12.93 | USD 51,720 | |
| 2024-08-12 | 2024-08-12 | B Purchase | Large shareholder |
757
+5.3%
15.88USD 12,023 |
757 +5.3% | 15.88 | USD 12,023 | |
| 2024-08-12 | 2024-08-12 | B Purchase | Large shareholder |
2,243
+1.8%
15.88USD 35,624 |
2,243 +1.8% | 15.88 | USD 35,624 | |
| 2024-08-12 | 2024-08-09 | B Purchase | Large shareholder |
3,000
+2.4%
14.89USD 44,679 |
3,000 +2.4% | 14.89 | USD 44,679 | |
| 2023-05-30 | 2023-05-25 | B Purchase | Non-Executive Director |
10,000
+100.0%
0.85USD 8,500 |
10,000 +100.0% | 0.85 | USD 8,500 | |
| 2022-05-16 | 2022-05-13 | B Purchase |
Chief Medical Officer Officer |
6,000
+inf%
1.71USD 10,260 |
6,000 +inf% | 1.71 | USD 10,260 | |
| 2021-09-01 | 2021-08-30 | S Sale |
Chief Development Officer Officer |
29,200
-86.3%
5.15USD 150,380 |
29,200 -86.3% | 5.15 | USD 150,380 | |
| 2021-09-01 | 2021-08-30 | S Sale |
Chief Development Officer Officer |
9,200
-21.4%
5.00USD 46,000 |
9,200 -21.4% | 5.00 | USD 46,000 | |
| 2020-07-22 | 2020-07-21 | S Sale |
Aquilo Capital Management, LLC Large shareholder |
1,900,000
-34.1%
2.95USD 5,605,000 |
1,900,000 -34.1% | 2.95 | USD 5,605,000 | |
| 2019-09-10 | 2019-09-06 | S Sale | Large shareholder |
1,128
-0.4%
4.50USD 5,075 |
1,128 -0.4% | 4.50 | USD 5,075 | |
| 2019-09-10 | 2019-09-06 | S Sale | Large shareholder |
25,720
-1.1%
4.50USD 115,725 |
25,720 -1.1% | 4.50 | USD 115,725 | |
| 2019-09-10 | 2019-09-06 | S Sale | Large shareholder |
23,152
-1.0%
4.50USD 104,170 |
23,152 -1.0% | 4.50 | USD 104,170 | |
| 2018-09-17 | 2018-09-14 | B Purchase |
KIRITSY CHRISTOPHER P |
5,000
+100.0%
5.11USD 25,525 |
5,000 +100.0% | 5.11 | USD 25,525 | |
| 2018-05-16 | 2018-05-15 | B Purchase |
GERAGHTY JAMES A |
10,000
+100.0%
5.75USD 57,500 |
10,000 +100.0% | 5.75 | USD 57,500 | |
| 2018-05-02 | 2018-04-30 | S Sale |
ORBIMED ADVISORS LLC Large shareholder |
10,400
-21.1%
6.35USD 66,040 |
10,400 -21.1% | 6.35 | USD 66,040 | |
| 2018-05-02 | 2018-04-30 | S Sale |
ORBIMED ADVISORS LLC Large shareholder |
989,600
-18.0%
6.35USD 6,283,960 |
989,600 -18.0% | 6.35 | USD 6,283,960 | |
| 2018-02-15 | 2018-02-13 | S Sale |
ORBIMED ADVISORS LLC Large shareholder |
75
-0.2%
8.98USD 674 |
75 -0.2% | 8.98 | USD 674 | |
| 2018-02-15 | 2018-02-13 | S Sale |
ORBIMED ADVISORS LLC Large shareholder |
7,822
-0.1%
8.98USD 70,242 |
7,822 -0.1% | 8.98 | USD 70,242 | |
| 2018-01-04 | 2018-01-03 | S Sale |
ORBIMED ADVISORS LLC Large shareholder |
16,128
-24.7%
7.35USD 118,541 |
16,128 -24.7% | 7.35 | USD 118,541 | |
| 2018-01-04 | 2018-01-03 | S Sale |
ORBIMED ADVISORS LLC Large shareholder |
1,693,492
-23.5%
7.35USD 12,447,166 |
1,693,492 -23.5% | 7.35 | USD 12,447,166 | |
| 2017-12-20 | 2017-12-18 | S Sale |
ORBIMED ADVISORS LLC Large shareholder |
1,392
-2.1%
5.70USD 7,934 |
1,392 -2.1% | 5.70 | USD 7,934 | |
| 2017-12-20 | 2017-12-18 | S Sale |
ORBIMED ADVISORS LLC Large shareholder |
146,243
-2.0%
5.70USD 833,585 |
146,243 -2.0% | 5.70 | USD 833,585 | |
| 2017-08-17 | 2017-08-17 | B Purchase |
GERAGHTY JAMES A |
10,000
+inf%
4.82USD 48,200 |
10,000 +inf% | 4.82 | USD 48,200 | |
| 2017-08-17 | 2017-08-17 | B Purchase |
Reine Allan See Remarks |
20,000
+44.4%
4.89USD 97,800 |
20,000 +44.4% | 4.89 | USD 97,800 | |
| 2017-08-17 | 2017-08-16 | B Purchase |
Reine Allan See Remarks |
45,000
+inf%
4.79USD 215,550 |
45,000 +inf% | 4.79 | USD 215,550 | |
| 2016-06-15 | 2016-06-14 | B Purchase |
Matis Louis SVP, Chief Development Officer Officer |
7,915
+379.6%
1.71USD 13,535 |
7,915 +379.6% | 1.71 | USD 13,535 | |
| 2016-06-15 | 2016-06-13 | B Purchase |
Matis Louis SVP, Chief Development Officer Officer |
2,085
+inf%
1.68USD 3,503 |
2,085 +inf% | 1.68 | USD 3,503 | |
| 2016-06-15 | 2016-06-13 | B Purchase |
Yoder Stephen S. President and CEO Executive Director |
6,000
+inf%
1.68USD 10,080 |
6,000 +inf% | 1.68 | USD 10,080 | |
| 2016-06-15 | 2016-06-13 | B Purchase |
DEPTULA-HICKS DARLENE M SVP, Chief Financial Officer Officer |
5,000
+inf%
1.66USD 8,300 |
5,000 +inf% | 1.66 | USD 8,300 | |
| 2015-07-08 | 2015-07-06 | B Purchase |
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder |
4,717
+7.8%
2.75USD 12,972 |
4,717 +7.8% | 2.75 | USD 12,972 | |
| 2015-07-08 | 2015-07-06 | B Purchase |
Khuong Chau Quang Non-Executive Director Large shareholder |
4,717
+7.8%
2.75USD 12,972 |
4,717 +7.8% | 2.75 | USD 12,972 | |
| 2015-07-08 | 2015-07-06 | B Purchase |
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder |
495,283
+7.4%
2.75USD 1,362,028 |
495,283 +7.4% | 2.75 | USD 1,362,028 | |
| 2015-07-08 | 2015-07-06 | B Purchase |
Khuong Chau Quang Non-Executive Director Large shareholder |
495,283
+7.4%
2.75USD 1,362,028 |
495,283 +7.4% | 2.75 | USD 1,362,028 |